AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics Nia JulianOctober 31, 2024 Facebook0 Twitter Pinterest0 0 Likes
